BioTech
Antibiotic innovation is ailing. ‘Brain drain’ may kill it
In today’s labor market, good help is hard to find. For companies developing antibiotics, it’s becoming nearly impossible. Three years ago, I became CEO of
Henry Skinner
June 3, 2024